Africa Takes Steps For Access To Medicines: Conference To Fight Fakes, Develop Local Production 23/05/2018 by Catherine Saez, Intellectual Property Watch 1 Comment A week after African ministers of health adopted a treaty for the establishment of an African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin’s efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines.
World Health Assembly Begins Discussion On Access To Medicines 22/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment On the second day of this week’s annual World Health Assembly, delegates began discussing the issue of “shortages of, and access to, medicines and vaccines.” It is generally held that access to safe, efficacious, and affordable medicines is of paramount importance to achieve the United Nations Sustainable Development Goals by 2030, but there seems to be no expeditious solution, and no lack of divergent views on how to get there.
Taiwan Left At Health Assembly Door; Police Ask Activists To Remove Political T-Shirts 22/05/2018 by Intellectual Property Watch 1 Comment For the second year in a row, Taiwan has not been invited to participate as an observer at the World Health Assembly taking place this week. Political dissent with China borne out of a change of government in Taiwan now refusing to recognise the “One China” principle resulted in Taiwan being left out of the World Health Organization. At the opening of the Assembly, several countries supported Taiwan, including the United States.
O Paradoxo Das Patentes No Brasil E Suas Implicações Para O Acesso A Medicamentos 22/05/2018 by Intellectual Property Watch 2 Comments O sistema de patentes foi supostamente projetado para permitir a recuperação do investimento em pesquisa e desenvolvimento (P&D) de um novo produto, através da venda sob exclusividade por um período de tempo. Vários estudos relacionaram preços altos de medicamentos à situação de monopólio estabelecida pelo sistema de patentes e outros direitos de monopólio (como a exclusividade de dados). É bastante estabelecido que a existência de uma patente pode levar a preços altos devido à condição de mercado em que um produtor pode operar com exclusividade. Vários estudos relacionaram preços elevados de medicamentos à situação de monopólio estabelecida pelo sistema de patentes e outros direitos de monopólio (como a exclusividade de dados). Na ausência de concorrência, um produtor pode cobrar praticamente qualquer preço pelo seu produto. A concorrência, portanto, pode promover uma redução significativa de preços e aumentar o acesso.
Patent Backlogs Fuel Efforts To Extend Pharma Patent Terms In Thailand And Brazil, AIDS Activists Say 18/05/2018 by Dugie Standeford for Intellectual Property Watch 17 Comments For a variety of reasons, Thailand and Brazil have huge backlogs of pharmaceutical patent applications. The delay in patent examinations is creating pressure on the countries to extend patent protection terms to the detriment of access to affordable medicines, AIDS organisations say.
The Patent Paradox In Brazil And Its Implications For Access To Medicines 18/05/2018 by Intellectual Property Watch 1 Comment Brazil is frequently pointed to as one of the countries in which fewer pharmaceutical patents are granted. The fact that there is a low number of patents granted could lead to the conclusion that medicines can be bought under competition and that the prices would be low. However, many medicines in Brazil are bought exclusively from one producer and usually at high prices. The situation of few granted patents, but many purchases under exclusivity due to absence of competition (which can lead to higher prices), is what we are calling the ‘patent paradox in Brazil’. In the absence of granted patents, what are the factors that lead to the situation of no competition and high prices in Brazil? This is the question that we, at the accessibsa: Innovation & Access to Medicines in India, Brazil & South Africa, aim to answer with a study currently being conducted at the Department of Medicines Policy and Pharmaceutical Services (NAF) of the Sergio Arouca National School of Public Health – ENSP/Fiocruz.
Data Collection For AI Solves Problems, Helps Researchers, Panellists Tell UN-Led Event 17/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment At a time when data collection has become a prickly subject and public defiance against large data-collecting companies such as Facebook, Google or Amazon has risen, a UN-led international summit on artificial intelligence this week sought to present the potential of the new technology in solving global problems. Data is the basic fuel of artificial intelligence, and panellists at the event showed how data collection has led to problem solving. For instance, the Chan-Zuckerberg Initiative hopes to give biomedical researchers the ability to tap into the global conversation and browse some 200 years of research.
TRIPS Flexibilities In High Demand 16/05/2018 by Intellectual Property Watch Leave a Comment Using flexibilities in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) has long been an issue of the developing world. But policymakers gathered at a meeting on access to health in Brussels today said there was an urgent need for European Union countries, too, to make more use of flexibilities.
Artificial Intelligence For Good: 3 Days To Discuss AI Solutions 15/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The second edition of an annual global summit on “artificial intelligence for good” spearheaded by the UN International Telecommunication Union opened today. A focus of the summit is how artificial intelligence can help advance the United Nations Sustainable Development Goals. The opening statements by UN heads, including the World Health Organization, showed growing interest in new technology to help in all kinds of areas such as health and agriculture.
UN Meeting Opens On Impact Of Science And Technology On Humanity 15/05/2018 by Damilola Adepeju for Intellectual Property Watch 1 Comment A United Nations meeting gathering ministers, high-level representatives, scientists and technology experts opened yesterday with a discussion of the impacts that rapid innovative trends in science and technology have on development, the UN Sustainable Development Goals (SDGs), and humanity itself.